181 related articles for article (PubMed ID: 33578810)
1. Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma.
Váraljai R; Horn S; Sucker A; Piercianek D; Schmitt V; Carpinteiro A; Becker KA; Reifenberger J; Roesch A; Felsberg J; Reifenberger G; Sure U; Schadendorf D; Helfrich I
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578810
[TBL] [Abstract][Full Text] [Related]
2. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
Harding JJ; Catalanotti F; Munhoz RR; Cheng DT; Yaqubie A; Kelly N; McDermott GC; Kersellius R; Merghoub T; Lacouture ME; Carvajal RD; Panageas KS; Berger MF; Rosen N; Solit DB; Chapman PB
Oncologist; 2015 Jul; 20(7):789-97. PubMed ID: 25956405
[TBL] [Abstract][Full Text] [Related]
4. Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Sci Rep; 2023 Jan; 13(1):444. PubMed ID: 36624125
[TBL] [Abstract][Full Text] [Related]
5. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.
In GK; Poorman K; Saul M; O'Day S; Farma JM; Olszanski AJ; Gordon MS; Thomas JS; Eisenberg B; Flaherty L; Weise A; Daveluy S; Gibney G; Atkins MB; Vanderwalde A
Oncotarget; 2020 Aug; 11(33):3118-3128. PubMed ID: 32913556
[TBL] [Abstract][Full Text] [Related]
7. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
8. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases.
Westphal D; Meinhardt M; Grützmann K; Schöne L; Steininger J; Neuhaus LT; Wiegel M; Schrimpf D; Aust DE; Schröck E; Baretton GB; Beissert S; Juratli TA; Schackert GG; Gravemeyer J; Becker JC; von Deimling A; Koelsche C; Klink B; Meier F; Schulz A; Muders MH; Seifert M
J Invest Dermatol; 2023 Jul; 143(7):1233-1245.e17. PubMed ID: 36716920
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
[TBL] [Abstract][Full Text] [Related]
10. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
[TBL] [Abstract][Full Text] [Related]
11. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Colombino M; Capone M; Lissia A; Cossu A; Rubino C; De Giorgi V; Massi D; Fonsatti E; Staibano S; Nappi O; Pagani E; Casula M; Manca A; Sini M; Franco R; Botti G; Caracò C; Mozzillo N; Ascierto PA; Palmieri G
J Clin Oncol; 2012 Jul; 30(20):2522-9. PubMed ID: 22614978
[TBL] [Abstract][Full Text] [Related]
12. Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases.
Gummadi T; Zhang BY; Valpione S; Kim C; Kottschade LA; Mittapalli RK; Chiarion-Sileni V; Pigozzo J; Elmquist WF; Dudek AZ
Melanoma Res; 2015 Feb; 25(1):75-9. PubMed ID: 25426645
[TBL] [Abstract][Full Text] [Related]
13. Genetic Characterization of Brain Metastases in the Era of Targeted Therapy.
Han CH; Brastianos PK
Front Oncol; 2017; 7():230. PubMed ID: 28993799
[TBL] [Abstract][Full Text] [Related]
14. Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Dummer R; Goldinger SM; Turtschi CP; Eggmann NB; Michielin O; Mitchell L; Veronese L; Hilfiker PR; Felderer L; Rinderknecht JD
Eur J Cancer; 2014 Feb; 50(3):611-21. PubMed ID: 24295639
[TBL] [Abstract][Full Text] [Related]
15. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
16. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
[TBL] [Abstract][Full Text] [Related]
17. Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Holbrook K; Lutzky J; Davies MA; Davis JM; Glitza IC; Amaria RN; Diab A; Patel SP; Amin A; Tawbi H
Cancer; 2020 Feb; 126(3):523-530. PubMed ID: 31658370
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review.
Avino A; Ion DE; Gheoca-Mutu DE; Abu-Baker A; Țigăran AE; Peligrad T; Hariga CS; Balcangiu-Stroescu AE; Jecan CR; Tudor A; Răducu L
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611601
[TBL] [Abstract][Full Text] [Related]
19. The genetics of uveal melanoma: current insights.
Helgadottir H; Höiom V
Appl Clin Genet; 2016; 9():147-55. PubMed ID: 27660484
[TBL] [Abstract][Full Text] [Related]
20. Clonal architectures and driver mutations in metastatic melanomas.
Ding L; Kim M; Kanchi KL; Dees ND; Lu C; Griffith M; Fenstermacher D; Sung H; Miller CA; Goetz B; Wendl MC; Griffith O; Cornelius LA; Linette GP; McMichael JF; Sondak VK; Fields RC; Ley TJ; Mulé JJ; Wilson RK; Weber JS
PLoS One; 2014; 9(11):e111153. PubMed ID: 25393105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
